JP2020527540A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020527540A5 JP2020527540A5 JP2019569444A JP2019569444A JP2020527540A5 JP 2020527540 A5 JP2020527540 A5 JP 2020527540A5 JP 2019569444 A JP2019569444 A JP 2019569444A JP 2019569444 A JP2019569444 A JP 2019569444A JP 2020527540 A5 JP2020527540 A5 JP 2020527540A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- dendritic cells
- bid
- dengue virus
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762520345P | 2017-06-15 | 2017-06-15 | |
| US62/520,345 | 2017-06-15 | ||
| PCT/US2018/037616 WO2018232166A1 (en) | 2017-06-15 | 2018-06-14 | Compositions and methods for cancer therapy with dengue virus and dendritic cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020527540A JP2020527540A (ja) | 2020-09-10 |
| JP2020527540A5 true JP2020527540A5 (https=) | 2021-07-26 |
Family
ID=64660234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019569444A Pending JP2020527540A (ja) | 2017-06-15 | 2018-06-14 | デングウイルスならびに樹状細胞を用いた癌治療のための組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20200121745A1 (https=) |
| EP (1) | EP3638303A4 (https=) |
| JP (1) | JP2020527540A (https=) |
| KR (1) | KR20200023375A (https=) |
| CN (1) | CN110996997A (https=) |
| AU (1) | AU2018285525A1 (https=) |
| EA (1) | EA201992863A1 (https=) |
| IL (1) | IL271442A (https=) |
| MX (1) | MX2019015194A (https=) |
| SG (1) | SG11201912163WA (https=) |
| WO (1) | WO2018232166A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107921063A (zh) | 2015-07-02 | 2018-04-17 | 普莱瓦克斯免疫肿瘤学公司 | 用于采用登革病毒与树突细胞的联合疗法的组合物及方法 |
| CN108291205A (zh) | 2015-09-26 | 2018-07-17 | 普莱瓦克斯免疫肿瘤学公司 | 用于产生树突细胞的组合物和方法 |
| JP2020500847A (ja) | 2016-11-16 | 2020-01-16 | プライムヴァックス イミュノ−オンコロジー，インク． | 癌の処置のための併用免疫療法 |
| EP3565567A4 (en) | 2017-01-04 | 2020-07-29 | Primevax Immuno-Oncology, Inc. | COMPOSITIONS AND METHODS OF THERAPY WITH DENGUE VIRUS |
| CN115666593B (zh) * | 2020-05-21 | 2025-11-25 | 国立大学法人大阪大学 | 上皮癌治疗药 |
| WO2022061811A1 (zh) * | 2020-09-27 | 2022-03-31 | 深圳华大生命科学研究院 | 药物组合物及其制备方法和应用 |
| CN116333969A (zh) * | 2023-02-01 | 2023-06-27 | 宁波荣安生物药业有限公司 | 一种狂犬病毒用Vero细胞培养方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1056834A2 (en) * | 1998-02-20 | 2000-12-06 | The Rockefeller University | Apoptotic cell-mediated antigen presentation to dendritic cells |
| US6524587B1 (en) * | 1998-05-05 | 2003-02-25 | Bruce W. Lyday | Hyperthermia and immunotherapy for leukemias lymphomas, and solid tumors |
| JP2002540168A (ja) * | 1999-03-26 | 2002-11-26 | ウォルター リード アーミー インスティテュート オブ リサーチ | 多価デングウイルスワクチン |
| CN107921063A (zh) * | 2015-07-02 | 2018-04-17 | 普莱瓦克斯免疫肿瘤学公司 | 用于采用登革病毒与树突细胞的联合疗法的组合物及方法 |
| CN108291205A (zh) * | 2015-09-26 | 2018-07-17 | 普莱瓦克斯免疫肿瘤学公司 | 用于产生树突细胞的组合物和方法 |
| EP3565567A4 (en) * | 2017-01-04 | 2020-07-29 | Primevax Immuno-Oncology, Inc. | COMPOSITIONS AND METHODS OF THERAPY WITH DENGUE VIRUS |
-
2018
- 2018-06-14 KR KR1020207001386A patent/KR20200023375A/ko not_active Ceased
- 2018-06-14 AU AU2018285525A patent/AU2018285525A1/en not_active Abandoned
- 2018-06-14 JP JP2019569444A patent/JP2020527540A/ja active Pending
- 2018-06-14 MX MX2019015194A patent/MX2019015194A/es unknown
- 2018-06-14 EP EP18817312.4A patent/EP3638303A4/en not_active Withdrawn
- 2018-06-14 CN CN201880052913.4A patent/CN110996997A/zh active Pending
- 2018-06-14 EA EA201992863A patent/EA201992863A1/ru unknown
- 2018-06-14 WO PCT/US2018/037616 patent/WO2018232166A1/en not_active Ceased
- 2018-06-14 SG SG11201912163WA patent/SG11201912163WA/en unknown
-
2019
- 2019-12-13 US US16/714,370 patent/US20200121745A1/en not_active Abandoned
- 2019-12-15 IL IL271442A patent/IL271442A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020527540A5 (https=) | ||
| JP2017048208A5 (https=) | ||
| JP2011251975A5 (https=) | ||
| JP2015157821A5 (https=) | ||
| CY1116874T1 (el) | Δοσολογικο σχημα για τη χορηγηση ενος cd19xcd3 αμφιειδικου αντισωματος | |
| RU2017132877A (ru) | Комбинация антагониста pd-1 и эрибулина для лечения рака | |
| JP2013505205A5 (https=) | ||
| CY1111259T1 (el) | Απο του στοματος εντερικη στερεα μορφη δοσολογιας ενος δισφωσφονικου που περιεχει παραγοντα χηλικης συμπλεξης | |
| JP2016512248A5 (https=) | ||
| EA200870480A1 (ru) | Новые композиции, стабилизирующие иммуногенные композиции и ингибирующие их осаждение | |
| MY141025A (en) | Dose forms | |
| RU2019112029A (ru) | Применение комбинации антитела к pd-1 и ингибитора vegfr в изготовлении лекарственного средства для лечения злокачественных новообразований | |
| ECSP088403A (es) | Formulacion farmaceutica de absorción oral y su método de administracion | |
| NZ620879A (en) | A novel formulation of indomethacin | |
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| TW200418517A (en) | Liquid pharmaceutical formulations of palonosetron | |
| MX2009012598A (es) | Formas de dosis que comprenden vx-950 y su regimen de dosificacion. | |
| JP2019530706A5 (https=) | ||
| JP2020523384A5 (https=) | ||
| Lei et al. | A vaccine delivery system promotes strong immune responses against SARS‐CoV‐2 variants | |
| JP2016512247A5 (https=) | ||
| JP2006508977A5 (https=) | ||
| Weiss | Immunotherapy for HIV infection | |
| JP2005508323A5 (https=) | ||
| JP2015500836A5 (https=) |